抗小鼠GITR抗体（克隆号DTA-1）引用文献

抗小鼠GITR单克隆抗体（克隆号DTA-1）引用文献如下：

1. Rational design of anti-GITR-based combination immunotherapy
2. Local Administration of GITR Agonistic Antibody Induces a Stronger Antitumor Immunity than Systemic Delivery
3. Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
4. Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITRL co-stimulation in vivo
5. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
6. Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
7. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
8. Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment
9. An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy
10. Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression
……

Syd Labs抗小鼠GITR重组抗体（克隆号DTA-1）：

Syd Labs 重组抗小鼠GITR单克隆抗体，大鼠IgG2b Lambda，体内实验级（In Vivo Grade Recombinant Anti-mouse GITR Monoclonal Antibody (Clone DTA-1), Rat IgG2b Lambda，货号：PA007169.r2b）是用哺乳动物细胞生产的重组抗体，其可变区序列是从大鼠抗小鼠GITR单克隆抗体（克隆号：DTA-1）中提取的，适用于体外和体内研究。

如果需要了解更多有关Syd Labs 重组抗小鼠GITR抗体(克隆号DTA-1)信息，比如Syd Labs 抗小鼠GITR重组抗体使用说明等资料，欢迎联系多找找获取。

特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。